NCT06099769 2026-02-25
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Clinical Trials
11 trialsNCT03225547 2025-12-23
Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
University of Chicago
Phase 2 Terminated
NCT02788981 2025-06-10
Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
University of Chicago
Phase 2 Active not recruiting
NCT01898312 2022-01-19
BRCA1/2 and Effect of Mifepristone on the Breast
Karolinska Institutet
Phase 2 Completed
NCT02642939 2020-10-19
Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Check, Jerome H., M.D., Ph.D.
Phase 2 Terminated
NCT00422201 2019-10-11
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
HRA Pharma
Phase 2 Terminated
NCT00459290 2018-07-18
Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
GOG Foundation
Phase 2 Completed
NCT00219778 2016-04-06
A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas
Poitiers University Hospital
Phase 2 Terminated
NCT00881140 2012-12-19
Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids
BioPro Medical Ltd
Phase 2 Completed
NCT00505739 2012-07-30
Mifepristone for Patients With Endometrial Cancer and LGESS
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00140478 2009-12-09
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2 Completed